Bioavailability and bioequivalence (BA/BE) studies in the Asia-Pacific region are gaining significant momentum. The rising cost of medicines worldwide is driving a strong demand for more affordable healthcare options. In this context, the generic drug market is emerging as a promising alternative, offering consumers access to medications at more reasonable prices. To bring generic drugs […]